The Federal Trade Commission is STILL accepting complaints from the public related to the shortage of #Adderall #Vyvanse #Methylphenidate #Concerta and ADHD medications generally.
One concern is ongoing private equity purchasing of generic pill press companies that is creating artificial scarcity deliberately.
Additional link from Additude Magazine: https://www.additudemag.com/adhd-medication-shortage-ftc-hhs-rfi/